# Personalized Neoantigen-pulsed Autologous Dendritic Cell Injections for Malignant Solid Tumors

> **NCT07752953** · NA · RECRUITING · sponsor: **ZSky Biotech Inc** · enrollment: 100 (estimated)

## Conditions studied

- Advanced Solid Tumor
- Cancer
- Malignant Solid Tumor

## Interventions

- **BIOLOGICAL:** Personalized neoantigen-pulsed autologous dendritic cell Injections （ZSNeo-DC）
- **DRUG:** Immune Checkpoint Inhibitors

## Key facts

- **NCT ID:** NCT07752953
- **Lead sponsor:** ZSky Biotech Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2029-08-10
- **Final completion:** 2030-08-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07752953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07752953, "Personalized Neoantigen-pulsed Autologous Dendritic Cell Injections for Malignant Solid Tumors". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07752953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*